Vernalis Considers US Deals As Prescription Cough/Cold Strategy Delivers
This article was originally published in The Pink Sheet Daily
Executive Summary
Vernalis launches its first long-acting liquid cough and cold product, Tuzistra XR, in the US as part of a revised business focus on generating sustainable revenues from low development risk, late-stage products.